Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries

References

• Back, S. E., Payne, R. L., Simpson, A. N., & Brady, K. T. (2010). Gender and prescription opioids: Findings from the national survey on drug use and health. Addictive Behaviors, 35(11), 1001–1007. https://doi.org/10.1016/j.addbeh.2010.06.018
   PubMed Web of Science ®Google Scholar
• Campbell, C. I., Weisner, C., Leresche, L., Ray, G. T., Saunders, K., Sullivan, M. D., Banta-Green, C. J., Merrill, J. O., Silverberg, M. J., Boudreau, D., Satre, D. D., & Von Korff, M. (2010). Age and gender trends in long-term opioid analgesic use for noncancer pain. American Journal of Public Health, 100(12), 2541–2547. https://doi.org/10.2105/AJPH.2009.180646
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse Treatment. (2006). Appendix B. Urine collection and testing procedures and alternative methods for monitoring drug use substance abuse: clinical issues in intensive outpatient treatment. Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2016). Guideline for prescribing opioids for chronic pain. Retrieved January 22, 2017, from https://www.cdc.gov/drugoverdose/prescribing/guideline.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2018). Quality improvement and care coordination: Implementing the CDC guideline for prescribing opioids for chronic pain. Atlanta, GA: National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention. Retrieved January 22, 2017, from https://www.cdc.gov/drugoverdose/pdf/prescribing/CDC-DUIP-QualityImprovementAndCareCoordination-508.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2019). Urine Drug Testing. Retrieved November 15, 2019, from https://www.cdc.gov/drugoverdose/pdf/prescribing/CDC-DUIP-UrineDrugTesting_FactSheet-508.pdf
   Google Scholar
• Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., GIlson, A. M., Kelter, A., Mauskop, A., O'Connor, P. G., Passik, S. D., Pasternak, G. W., Portenoy, R. K., Rich, B. A., Roberts, R. G., Todd, K. H., & Miaskowski, C. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain, 10(2), 113-130. https://doi.org/10.1016/j.jpain.2008.10.008
   Google Scholar
• Chua, I., Petrides, A. K., Schiff, G. D., Ransohoff, J. R., Kantartjis, M., Streid, J., Demetriou, C. A., & Melanson, S. E. F. (2020). Provider misinterpretation, documentation, and follow-up of definitive urine drug testing results. Journal of General Internal Medicine, 35(1), 283–290. https://doi.org/10.1007/s11606-019-05514-5
   PubMed Web of Science ®Google Scholar
• Cone, E. J., & Caplan, Y. H. (2009). Urine toxicology testing in chronic pain management. Postgraduate Medicine, 121(4), 91–102. https://doi.org/10.3810/pgm.2009.07.2035
   PubMed Web of Science ®Google Scholar
• Dobscha, S. K., Morasco, B. J., Duckart, J. P., Macey, T., & Deyo, R. A. (2013). Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical Journal of Pain, 29(2), 102–108. https://doi.org/10.1097/AJP.0b013e3182490bdb
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
   PubMed Web of Science ®Google Scholar
• Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N. M., Shilliday, B. B., DeWalt, D. A., & Pignone, M. P. (2006). Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research, 6(1), 46. https://doi.org/10.1186/1472-6963-6-46
   PubMedGoogle Scholar
• Larochelle, M. R., Cocoros, N. M., Popovic, J., Dee, E. C., Kornegay, C., Ju, J., & Racoosin, J. A. (2017). Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in food and drug administration's sentinel system. Journal of Opioid Management, 13(5), 315–327. https://doi.org/10.5055/jom.2017.0400
   PubMedGoogle Scholar
• Melanson, S. E. F., & Petrides, A. K. (2017). Economics of pain management testing. The Journal of Applied Laboratory Medicine, 2(4), 587–597. https://doi.org/10.1373/jalm.2017.023010
   Google Scholar
• Pergolizzi, J. V., Jr, Gharibo, C., Passik, S., Labhsetwar, S., Taylor, R., Jr, Pergolizzi, J. S., & Müller-Schwefe, G. (2012). Dynamic risk factors in the misuse of opioid analgesics. Journal of Psychosomatic Research, 72(6), 443–451. https://doi.org/10.1016/j.jpsychores.2012.02.009
   PubMed Web of Science ®Google Scholar
• Seth, P., Rudd, R. A., Noonan, R. K., & Haegerich, T. M. (2018). Quantifying the epidemic of prescription opioid overdose deaths: American Public Health Association. American Journal of Public Health, 108(4), 500–502. https://doi.org/10.2105/AJPH.2017.304265
   PubMed Web of Science ®Google Scholar
• Starrels, J. L., Becker, W. C., Alford, D. P., Kapoor, A., Williams, A. R., & Turner, B. J. (2010). Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Annals of Internal Medicine, 152(11), 712–720. https://doi.org/10.7326/0003-4819-152-11-201006010-00004 http://annals.org/data/Journals/AIM/20207/0000605-201006010-00004.pdf
   PubMed Web of Science ®Google Scholar
• Starrels, J. L., Becker, W. C., Weiner, M. G., Li, X., Heo, M., & Turner, B. J. (2011). Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. Journal of General Internal Medicine, 26(9), 958–964. https://doi.org/10.1007/s11606-011-1648-2
   PubMed Web of Science ®Google Scholar
• Sullivan, M. D., Edlund, M. J., Fan, M.-Y., DeVries, A., Braden, J. B., & Martin, B. C. (2010). Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain, 150(2), 332–339. https://doi.org/10.1016/j.pain.2010.05.020
   PubMed Web of Science ®Google Scholar
• Turk, D. C., Swanson, K. S., & Gatchel, R. J. (2008). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. The Clinical Journal of Pain, 24(6), 497–508. https://doi.org/10.1097/AJP.0b013e31816b1070
   PubMed Web of Science ®Google Scholar
• University of Washington, DOPM. (2010). Urine Drug Testing (UDT) interpretative algorithm for monitoring opioid treatment. Retrieved November 15, 2019, from https://depts.washington.edu/anesth/care/pain/telepain/mini-site/docs/UW-UDTinterpretationAlgorithm.pdf
   Google Scholar
• Von Korff, M., Saunders, K., Ray, G. T., Boudreau, D., Campbell, C., Merrill, J., Sullivan, M. D., Rutter, C. M., Silverberg, M. J., Banta-Green, C., & Weisner, C. (2008). De facto long-term opioid therapy for noncancer pain. The Clinical Journal of Pain, 24(6), 521–527. doi: 10.1097/AJP.0b013e318169d03b.
   PubMed Web of Science ®Google Scholar
• White, A. G., Birnbaum, H. G., Schiller, M., Tang, J., & Katz, N. P. (2009). Analytic models to identify patients at risk for prescription opioid abuse. The American Journal of Managed Care, 15(12), 897–906.
   PubMed Web of Science ®Google Scholar
• Xue, X., Xie, X., Gunter, M., Rohan, T. E., Wassertheil-Smoller, S., Ho, G. Y. F., Cirillo, D., Yu, H., & Strickler, H. D. (2013). Testing the proportional hazards assumption in case-cohort analysis. BMC Medical Research Methodology, 13(88), 88–97. https://doi.org/10.1186/1471-2288-13-88
   PubMedGoogle Scholar